Skip to main content
SpringerLink
Log in

Infectious Complications of Hemodialysis in Children

  • Chapter
  • First Online:
Pediatric Dialysis

Abstract

Infections significantly complicate the care of children on hemodialysis and usually are associated with the use of a hemodialysis catheter for dialysis access. Infections of arteriovenous fistulae and arteriovenous grafts are uncommon, but many children on hemodialysis rely on a catheter, either while permanent access is being created or for long-term access. Catheter exit site infections most often occur independently of catheter-related bloodstream infections and are usually amenable to treatment with increased skin antisepsis and oral antibiotic provision. Tunnel infections can be more complicated and sometimes require surgical intervention and lead to catheter replacement. Catheter-related bloodstream infections are generally caused by skin flora and are often related to contamination of an open dialysis catheter hub during a dialysis treatment. Bacterial colonization of catheters and the development of biofilm also predispose to bloodstream infections. Broad-spectrum antibiotics such as vancomycin and ceftazidime are typically used for empiric antibiotic therapy. Antibiotic locks have been shown to reduce catheter infections and also augment cure rates. Catheter replacement or removal may be necessary, especially with infection with difficult-to-treat organisms or with persistent or recurrent infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shroff R, Calder F, Bakkaloglu S, Nagler EV, Stuart S, Stronach L, Schmitt CP, Heckert KH, Bourquelot P, Wagner AM, Paglialonga F, Mitra S, Stefanidis CJ on behalf of the European Society for Pediatric Nephrology Dialysis Working Group. Vascular access in children requiring maintenance haemodialysis: a consensus document by the European Society for Paediatric Nephrology Dialysis Working Group. Nephrol Dial Transplant. 2019;34:1–20.

    Article  Google Scholar 

  2. Borzych-Duzalka D, Shroff R, Ariceta G, Yap YC, Paglialonga F, Xu H, Kang HG, Thumfart J, Aysun KB, Stefanidis CJ, Fila M, Sever L, Vondrak K, Szabo AJ, Szczepanska M, Ranchin B, Holtta T, Zaloszyc A, Bilge I, Warady BA, Schaefer F, Schmitt CP. Vascular access choice, complications, and outcomes in children on maintenance hemodialysis: findings from the International Pediatric Hemodialysis Network (IPHN) Registry. Am J Kidney Dis. 2019;74:193–202.

    Article  PubMed  Google Scholar 

  3. 2018 USRDS annual data report, volume 2: ESRD in the United States: Chapter 7: ESRD among children, adolescents and young adults. https://www.usrds.org/2018/view/v2_07.aspx.

  4. Baracco R, Mattoo T, Jain A, Kapur G, Valentini RP. Reducing central venous catheters in chronic hemodialysis- a commitment to arteriovenous fistula creation in children. Pediatr Nephrol. 2014;29(10):2013–20.

    Article  PubMed  Google Scholar 

  5. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44:779–91.

    Article  PubMed  Google Scholar 

  6. Onder AM, Chandar J, Coakley S, Abitbol CL, Montane B, Zilleruelo G. Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis. Pediatr Nephrol. 2006;21:1452–8.

    Article  PubMed  Google Scholar 

  7. Paglialonga F, Esposito S, Edefonti A, Principi N. Catheter-related infections in children treated with hemodialysis. Pediatr Nephrol. 2004;19:1324–33.

    Article  PubMed  Google Scholar 

  8. Stefanidis C. Prevention of catheter-related bacteremia in children on hemodialysis: time for action. Pediatr Nephrol. 2009;24:2087–95.

    Article  PubMed  Google Scholar 

  9. Dryden MS, Samson A, Ludlam HA, et al. Infective complications associated with the use of the Quinton “Permcath” for long-term central vascular access in haemodialysis. J Hosp Infect. 1991;19:257–62.

    Article  CAS  PubMed  Google Scholar 

  10. Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549–64.

    Article  PubMed  Google Scholar 

  11. Shingarev R, Barker-Finkel J, Allon M. Natural history of tunneled dialysis catheters placed for hemodialysis initiation. J Vasc Interv Radiol. 2013;24:1289–95.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Schwab SJ, Beathard GA. The hemodialysis catheter conundrum: hate living with them, but can’t live without them. Kidney Int. 1999;56:1–17.

    Article  CAS  PubMed  Google Scholar 

  13. Pastan S, Soucie M, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62:620–6.

    Article  PubMed  Google Scholar 

  14. Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ, for the HEMO Study Group. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol. 2003;14:1863–70.

    Article  PubMed  Google Scholar 

  15. Fadrowski JJ, Hwang W, Frankenfield DL, Fivush BA, Neu AM, Furth SL. Clinical course associated with vascular access type in a national cohort of adolescents who receive hemodialysis: findings from the clinical performance measures and US renal data system projects. Clin J Am Soc Nephrol. 2006;1:987–92.

    Article  PubMed  Google Scholar 

  16. Brem AS, Lambert C, Kitsen J, Somers M, Shemin DG. Chronic dialysis and access-related morbidities in children. Nephrol Dial Transplant. 2005;34:278–89.

    Google Scholar 

  17. Fadrowski JJ, Hwang W, Neu AM, Fivush BA, Furth SL. Patterns of use of vascular catheters for hemodialysis in children in the United States. Am J Kidney Dis. 2009;53:91–8.

    Article  PubMed  Google Scholar 

  18. Lofaro D, Vogelzang JL, van Stralen KJ, Jager KJ, Groothoff JW. Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age. Pediatr Nephrol. 2016;31:315–23.

    Article  PubMed  Google Scholar 

  19. Hayes WN, Watson AR, Callaghan N, Wright E, Stefanidis CJ, European Pediatric Dialysis Working Group. Vascular access: choice and complications in European pediatric hemodialysis units. Pediatr Nephrol. 2012;27:999–1004.

    Article  PubMed  Google Scholar 

  20. Sheth R, Kale A, Brewer ED, Brandt ML, Nuchtern JG, Goldstein SL. Successful use of Tesio catheters in pediatric patients receiving chronic hemodialysis. Am J Kidney Dis. 2001;38:553–9.

    Article  CAS  PubMed  Google Scholar 

  21. Kovalski Y, Cleper R, Krause I, Davidovits M. Hemodialysis in children weighing less than 15 kg: a single-center experience. Pediatr Nephrol. 2007;22:2105–10.

    Article  PubMed  Google Scholar 

  22. Lee T, Barker J, Allon M. Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes. Am J Kidney Dis. 2005;46:501–8.

    Article  PubMed  Google Scholar 

  23. Eisenstein I, Tarabeith M, Magen D, Pollack S, Kassis I, Ofer A, Engel A, Zelikovic I. Low infection rates and prolonged survival times of hemodialysis catheters in infants and children. Clin J Am Soc Nephrol. 2011;6:793–8.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Sharma A, Zilleruelo G, Abitbol CL, Montane B, Strauss J. Survival and complications of cuffed central venous catheters in children and young adults on chronic hemodialysis. Pediatr Nephrol. 1999;13:245–8.

    Article  CAS  PubMed  Google Scholar 

  25. Goldstein SL, Macierowski CT, Jabs K. Hemodialysis catheter survival and complications in children and adolescents. Pediatr Nephrol. 1997;11:74–7.

    Article  CAS  PubMed  Google Scholar 

  26. Ramage IJ, Bailie A, Tyerman KS, McColl JH, Pollard SG, Fitzpatrick MM. Vascular access survival in children and young adults receiving long-term hemodialysis. Am J Kidney Dis. 2005;45:708–15.

    Article  PubMed  Google Scholar 

  27. Marsenic O, Rodean J, Richardson T, Swartz S, Claes D, Day JC, Warady B, Nue A, Scope Investigators. Tunneled hemodialysis catheter care practices and blood stream infection rate in children: results from the SCOPE collaborative. Pediatr Nephrol. 2020;35:135–43.

    Article  PubMed  Google Scholar 

  28. Chawla PG, Nevins TE. Management of hemodialysis catheter-related bacteremia- a 10-year experience. Pediatr Nephrol. 2000;14:198–202.

    Article  CAS  PubMed  Google Scholar 

  29. Araya CE, Fennell RS, Neilberger RE, Dharnidharka VR. Hemodialysis catheter-related bacteremia in children: increasing antibiotic resistance and changing bacteriological profile. Am J Kidney Dis. 2007;50:119–23.

    Article  PubMed  Google Scholar 

  30. Onder AM, Chandar J, Simon N, Saint-Vil M, Francoeur D, Nwobi O, Abitbol CL, Zilleruelo G. Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks. Pediatr Nephrol. 2008;28:457–64.

    Article  Google Scholar 

  31. Von Baum H, Schehl J, Geiss HK, Schaefer F. Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Mid-European Pediatric Peritoneal Dialysis Study Group. Clin Infect Dis. 1999;29:912–6.

    Article  Google Scholar 

  32. Berns JS. Infection with antimicrobial-resistant microorganism in dialysis patients. Semin Dial. 2003;16:30–7.

    Article  PubMed  Google Scholar 

  33. Landry DL, Sweet SJ, Gobeille SL, et al. Long-term gentamicin lock catheter prophylaxis is associated with gentamicin-resistant Gram –positive bacteremia in chronic hemodialysis. Clin J Am Soc Nephrol. 2010;5:1799–804.

    Article  PubMed  PubMed Central  Google Scholar 

  34. O’Grady NP, Alexander M, Burn LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S. Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. 2011. http://www.cdc.gov/hicpac/pdf/guidelines/bsi-guielines-2011.pdf. Accessed om 12/26/2018.

  35. Patel PR, Yi SH, Booth S, Bren V, Downham G, Hess S, Kelley K, Lincoln M, Morrissette K, Lindberg C, Jernigan JA, Kallen AJ. Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: a quality improvement report. 2013. Am J Kidney Dis. 2013;62:322–30.

    Article  PubMed  Google Scholar 

  36. Centers for Disease Control and Prevention. Dialysis safety: infection prevention tools. Available at: https://www.cdc.gov/dialysis/prevention-tools/core-interventions.html. Accessed at 12/27/2019.

  37. Patel PR, Brinsley-Rainisch K. The making dialysis safer for patients coalition: a new partnership to prevent hemodialysis-related infections. Clin J Am Soc Nephrol. 2018;13:175–81.

    Article  Google Scholar 

  38. NTDS: promoting infection prevention in dialysis facilities 2017 annual report. Available at: http://www.asn-online.org/ntds.

  39. Hoshal VL Jr, Ause RG, Hoskins PA. Fibrin sleeve formation on indwelling subclavian central venous catheter. Arch Surg. 1971;102:253–8.

    Article  Google Scholar 

  40. Tapia G, Yee J. Biofilm: its relevance in kidney disease. Adv Chronic Kidney Dis. 2006;13:215–24.

    Article  PubMed  Google Scholar 

  41. Passerini L, Lam K, Costerton JW, King EG. Biofilms on indwelling vascular catheters. Crit Care Med. 1992;20:665–73.

    Article  CAS  PubMed  Google Scholar 

  42. Costerton JW, Steward PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22.

    Article  CAS  PubMed  Google Scholar 

  43. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001;33:1387–92.

    Article  CAS  PubMed  Google Scholar 

  44. Dasgupta MK. Biofilms and infection in dialysis patients. Semin Dial. 2002;15:338–46.

    Article  PubMed  Google Scholar 

  45. Raad I, Costerton JW, Sabharwal U, Sacilowski M, Anaisse E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168:400–7.

    Article  CAS  PubMed  Google Scholar 

  46. Fux CA, Costerton JW, Stewart PS, et al. Survival strategies of infectious biofilms. Trends Microbiol. 2005;13:34–40.

    Article  CAS  PubMed  Google Scholar 

  47. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135–8.

    Article  CAS  PubMed  Google Scholar 

  48. Jones SM, Ravani P, Hemmelgam BR, Muruve D, MacRae JM. Morphometric and biological characterization of biofilm in tunneled hemodialysis catheters. Am J Kidney Dis. 2011;57:449–55.

    Article  CAS  PubMed  Google Scholar 

  49. Ramanathan V, Riosa S, Al-Sharif AH, Mansouri MD, Tranchina A, Kayyal T, Abreo A, Aslam S, Nassar G, Darouiche RO. Characteristics of biofilm on tunneled cuffed hemodialysis catheters in the presence and absence of clinical infection. Am J Kidney Dis. 2012;60:976–82.

    Article  PubMed  Google Scholar 

  50. Kanaa M, Wright MJ, Sandoe JA. Examination of tunneled hemodialysis catheters using scanning electron microscopy. Clin Microbiol Infect. 2010;16:780–6.

    Article  CAS  PubMed  Google Scholar 

  51. Verbeke F, Haug U, Dhondt A, Beck W, Schnell A, Dietrich R, Deppisch R, Vanholder R. The role of polymer surface degradation and barium sulphate release in the pathogenesis of catheter-related infection. Nephrol Dial Transplant. 2010;25:1207–13.

    Article  CAS  PubMed  Google Scholar 

  52. Shanks RMQ, Sargent JL, Martinez RM, et al. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant. 2006;21:2247–55.

    Article  CAS  PubMed  Google Scholar 

  53. Bosma JW, Siegert GE, Peerbooms PG, et al. Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial. Nephrol Dial Transplant. 2010;25:1213–7.

    Article  CAS  PubMed  Google Scholar 

  54. Cheesbrough JS, Finch RG, Burden RP. A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis. 1986;154:579–84.

    Article  CAS  PubMed  Google Scholar 

  55. Almirall J, Gonzalez J, Rello J, et al. Infection of hemodialysis catheters: incidence and mechanisms. Am J Nephrol. 1989;9:454–7.

    Article  CAS  PubMed  Google Scholar 

  56. Powe NR, Jaar B, Furth SL. Septicemia in dialysis patients: incidence, risk factors and prognosis. Kidney Int. 1999;55:1081–90.

    Article  CAS  PubMed  Google Scholar 

  57. Kaplowitz LG, Comstock JA, Landwehr DM. A prospective study of infections in hemodialysis patients: patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol. 1988;9:534–41.

    Article  CAS  PubMed  Google Scholar 

  58. Hoen B, Kessler M, Hestin D, Mayeux D. Risk factors for bacterial infections in chronic hemodialysis adult patients: a multicenter prospective survey. Nephrol Dial Transplant. 1995;10:377–81.

    CAS  PubMed  Google Scholar 

  59. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol. 1998;9:869–76.

    Article  CAS  PubMed  Google Scholar 

  60. Jean G, Charra B, Chazot C, Vanel T, Terrat JC, Hurot JM, Laurent G. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron. 2002;91:399–405.

    Article  CAS  PubMed  Google Scholar 

  61. Mokrzycki MH, Schroppel B, Von Gersdorff G, Rush H, Zdunek MP, Feingold R. Tunneled –cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus. J Am Soc Nephrol. 2000;11:2122–7.

    Article  CAS  PubMed  Google Scholar 

  62. Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunnelled haemodialysis catheter bacteremia: risk factors for bacteremia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 2006;21:1024–31.

    Article  PubMed  Google Scholar 

  63. Jaber BL. Bacterial infections in hemodialysis patients: pathogenesis and prevention. Kidney Int. 2005;67:2508–19.

    Article  PubMed  Google Scholar 

  64. Onder AM, Chandar J, Saint-Vil M, Lopez-Mitnik G, Abitbol CL, Zilleruelo G. Catheter survival and comparison of catheter exchange methods in children on hemodialysis. Pediatr Nephrol. 2007;22:1355–61.

    Article  PubMed  Google Scholar 

  65. Sirken G, Raja R, Rizkala AR. Identification of infectious risk factors in maintenance hemodialysis patients: the role of intravenous iron. J Am Soc Nephrol. 2004;15:627A.

    Google Scholar 

  66. Brewster UC, Coca SG, Reilly RF, Perazella MA. Effect of intravenous iron on hemodialysis catheter microbial colonization and blood borne infection. Nephrology (Carlton). 2005;10:124–8.

    Article  CAS  Google Scholar 

  67. Boelaert JR, Daneels RF, Schurgers ML, Matthys EG, Gordts BZ, Van Landuyt HW. Iron overload in haemodialysis patients increases the risk of bacteremia: a prospective study. Nephrol Dial Transplant. 1990;5:130–4.

    Article  CAS  PubMed  Google Scholar 

  68. Tielemans CL, Lenclud CM, Wens R, Collart FE, Dratwa M. Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections: beneficial effects of desferrioxamine. Nephrol Dial Transplant. 1989;4:883–7.

    Article  CAS  PubMed  Google Scholar 

  69. Teehan GS, Bahdouch D, Ruthazer R, et al. Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis. 2004;38:1090–5.

    Article  PubMed  Google Scholar 

  70. Lumsden AB, MacDonald MJ, Allen RC, Dodson TF. Hemodialysis access in the pediatric population. Am J Surg. 1994;168:197–201.

    Article  CAS  PubMed  Google Scholar 

  71. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall A, Allon M. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int. 2000;57:2151–5.

    Article  CAS  PubMed  Google Scholar 

  72. Onder AM, Chandar J, Billings AA, Simon N, Diaz R, Francoeur D, Abitbol CL, Zilleruelo G. Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia. Clin J Am Soc Nephrol. 2008;3:1048–56.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Allon M. Treatment guidelines for dialysis catheter-related bacteremia: an update. Am J Kidney Dis. 2009;54:13–7.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.

    Article  CAS  PubMed  Google Scholar 

  75. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for vascular access 2006. Am J Kidney Dis. 2006;48(Suppl 1):S176–S322.

    Google Scholar 

  76. Haimi-Cohen Y, Vellozi EM, Rubin LG. Concentration of Staphylococcus epidermidis in simulated pediatric blood cultures correlates with time to positive results with the automated, continuously monitored BACTEC blood culture system. J Clin Microbiol. 2002;40:898–901.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Pelletier FQ, Joarder M, Poutanen SM, Lok CE. Evaluating approaches for the diagnosis of hemodialysis catheter-related bloodstream infections. Clin J Am Soc Nephrol. 2016;11:847–54.

    Article  CAS  Google Scholar 

  78. Lumsden AB, MacDonald MJ, Isiklar H, Martin LG, Kikeri D, Harker LA, Allen RC. Central venous stenosis in the hemodialysis patient: incidence and efficacy of endovascular treatment. Cardiovasc Surg. 1997;5:504–9.

    Article  CAS  PubMed  Google Scholar 

  79. Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, Allon M. Management of hemodialysis catheter-related bacteremia with an adjunctive lock solution. Kidney Int. 2002;61:1136–42.

    Article  PubMed  Google Scholar 

  80. Onder AM, Billings AA, Chandar J, Nield L, Francoeur D, Simon N, Abitbol CL, Zilleruelo G. Antibiotic lock solutions allow less systemic antibiotic exposure and less catheter malfunction without adversely affecting antimicrobial resistance patterns. Hemodial Int. 2013;17:75–85.

    Article  PubMed  Google Scholar 

  81. Farrington CA, Allon M. Management of the hemodialysis patient with catheter-related bloodstream infection. Clin J Am Soc Nephrol. 2019;14:611–3.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Shaffer D. Catheter-related sepsis complicating long-term, tunneled central venous dialysis catheters: management by guide-wire exchange. Am J Kidney Dis. 1995;25:593–6.

    Article  CAS  PubMed  Google Scholar 

  83. Robinson D, Suhocki P, Schwab SJ. Treatment of infected tunneled venous access hemodialysis catheter with guidewire exchange. Kidney Int. 1998;53:1792–4.

    Article  CAS  PubMed  Google Scholar 

  84. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol. 1999;10:1045–9.

    Article  CAS  PubMed  Google Scholar 

  85. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13:686–707.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Fishbane S, Cunha BA, Mittal SK, Ruggian J, Shea K, Schoch PE. Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use. Infect Control Hosp Epidemiol. 1999;7:461–2.

    Article  Google Scholar 

  87. Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2008;52:192–7.

    Article  CAS  PubMed  Google Scholar 

  88. Sowinski KM, Magner SJ, Lucksiri A, Scott MK, Hamburger RJ, Mueller BA. Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis and recommended dosing. Clin J Am Soc Nephrol. 2008;3:355–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Sychev D, Maya ID, Allon M. Clinical outcomes of dialysis catheter-related candidemia in hemodialysis patients. Clin J Am Soc Nephrol. 2009;4:1102–5.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Lewis SS, Sexton DJ. Metastatic complications of blood stream infections in hemodialysis patients. Semin Dial. 2013;26:47–53.

    Article  PubMed  Google Scholar 

  91. Philipneri M, Al-Aly Z, Amin K, et al. Routine replacement of tunneled cuffed hemodialysis catheters eliminates para-spinal/vertebral infections in patients with catheter associated bacteremia. Am J Nephrol. 2003;23:202–7.

    Article  PubMed  Google Scholar 

  92. Marr KA, Sexton D, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med. 1997;127:275–80.

    Article  CAS  PubMed  Google Scholar 

  93. Kovalik E, Albers F, Raymond J, Conlon P. A clustering of cases of spinal epidural abscess in hemodialysis patients: risks of salvaging access catheters in cases of infection. J Am Soc Nephrol. 1996;7:2264–7.

    Article  CAS  PubMed  Google Scholar 

  94. Bastani B, Minton J, Islam S. Insufficient penetration of systemic vancomycin into the PermCath lumen. Nephrol Dial Transplant. 2000;15:1035–7.

    Article  CAS  PubMed  Google Scholar 

  95. Obrador GT, Levenson DJ. Spinal epidural abscess in hemodialysis patients: report of three cases and review of the literature. Am J Kidney Dis. 1996;27:75–83.

    Article  CAS  PubMed  Google Scholar 

  96. Bailey E, Berry N, Cheesbrough JS. Antimicrobial lock therapy for catheter-related bacteremia among patients on maintenance haemodialysis. J Antimicrob Chemother. 2002;50:615–7.

    Article  CAS  PubMed  Google Scholar 

  97. Vardhan A, Davies J, Daryanani I, Crowe A, McClelland P. Treatment of haemodialysis catheter-related infections. Nephrol Dial Transplant. 2002;17:1149–50.

    Article  PubMed  Google Scholar 

  98. Ghani MK, Boccalandro F, Denktas AE, et al. Right atrial thrombus formation associated with central venous catheters utilization in hemodialysis patients. Intensive Care Med. 2003;29:1829–32.

    Article  PubMed  Google Scholar 

  99. Aslam S. Effect of antibacterials on biofilms. Am J Infect Control. 2008;36:e09–11.

    Article  Google Scholar 

  100. Nielsen J, Ladefoged SD, Kolmos HJ. Dialysis catheter-related septicaemia- focus on Staphylococcus aureus septicemia. Nephrol Dial Transplant. 1998;13:2847–55.

    Article  CAS  PubMed  Google Scholar 

  101. Fisher M, Golestaneh L, Allon M, Abreo K, Mokrzycki MH. Prevention of bloodstream infections in patients undergoing hemodialysis. Clin J Am Soc Nephrol. 2020;15:132–151; pushlished online 12/2019.

    Google Scholar 

  102. Raad I, Rosenblatt J, Reitzel R, Jiang Y, Dvorak T, Hachem R. Chelator-based catheter lock solutions in eradicating organisms in biofilm. Antimicrob Agents Chemother. 2013;57:586–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Capdevila JA, Segarra A, Planes AM, Ramirez-Arellano M, Pahissa A, Pierra L, Martinez-Vazquez JM. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant. 1993;8:231–4.

    CAS  PubMed  Google Scholar 

  104. Johnson DC, Johnson FL, Goldman S. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr Infect Dis J. 1994;13:930–1.

    Article  CAS  PubMed  Google Scholar 

  105. Aslam S, Vaida F, Ritter M, Mehta RL. Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia. J Am Soc Nephrol. 2014;25:2927–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Onder AM, Billings AA, Chandar J, Francoeur D, Simon N, Abitbol CL, Zilleruelo G. PREFABL: predictors of failure of antibiotic locks for the treatment of catheter-related bacteremia. Nephrol Dial Transplant. 2010;25:3686–93.

    Article  PubMed  Google Scholar 

  107. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725–32.

    Article  CAS  PubMed  Google Scholar 

  108. Johnson LB, Jose J, Yousif F, Pawlak J. Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol. 2009;30:4–8.

    Article  PubMed  Google Scholar 

  109. Bloom BS, Fendrick AM, Chernew ME, Patel P. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. Am J Kidney Dis. 1996;27:687–94.

    Article  CAS  PubMed  Google Scholar 

  110. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520–32.

    Article  CAS  PubMed  Google Scholar 

  111. Langer JM, Cohen RM, Berns JS, Chittams J, Cooper ET, Trerotola SO. Staphylococcus-infected tunneled dialysis catheters: is over-the-wire exchange an appropriate management option? Cardiovasc Intervent Radiol. 2011;34:1230–5.

    Article  PubMed  Google Scholar 

  112. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, Zuravleff JJ. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med. 1986;315:91–6.

    Article  CAS  PubMed  Google Scholar 

  113. Boelaert JR, De Smedt RA, De Baere YA, Godard CA, Matthys EG, Schurgers ML, Daneels RF, Gordts BZ, Van Landuyt HW. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in hemodialysis patients. Nephrol Dial Transplant. 1989;4:278–81.

    Article  CAS  PubMed  Google Scholar 

  114. Kluytmans JA, Manders MJ, van Bommel E, Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol. 1996;17:793–7.

    Article  CAS  PubMed  Google Scholar 

  115. Grothe C, Taminato M, Belasco A, Sesso R, Barbosa D. Screening and treatment of Staphylococcus aureus in patients undergoing hemodialysis: a systemic review and meta-analysis. BC Nephrol. 2014;15:202–10.

    CAS  Google Scholar 

  116. Teo BW, Low SJX, Ding Y, Koh TH, Hsu LY. High prevalence of mupirocin-resistant staphylococci in a dialysis unit where mupirocin and chlorhexidine are routinely used for prevention of catheter-related infections. J Med Microbiol. 2011;60:865–7.

    Article  PubMed  Google Scholar 

  117. Annigeri R, Conly J, Vas S, Dedier H, Prakashan KP, Bargman JM, Jassal V, Oreopoulos D. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int. 2001;21:554–9.

    Article  CAS  PubMed  Google Scholar 

  118. Cookson BD. Mupirocin resistance in staphylococci. J Antimicrob Chemother. 1990;25:497–501.

    Article  CAS  PubMed  Google Scholar 

  119. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol. 1996;17:811–3.

    Article  CAS  PubMed  Google Scholar 

  120. Onder AM, Chandar J, Billings AA, Diaz R, Francoeur D, Abitbol CL, Zilleruelo G. Chlorhexidine-based antiseptic solutions effectively reduce catheter-related bacteremia. Pediatr Nephrol. 2009;24:1741–7.

    Article  PubMed  Google Scholar 

  121. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136:792–801.

    Article  CAS  PubMed  Google Scholar 

  122. Mimoz O, Villeminey S, Ragot S, Dahyot-Fizelier C, Laksiri L, Petitpas F, Debaene B. Chlorhexidine-based antiseptic solution versus alcohol –based povidone- iodine for central venous catheter care. Arch Intern Med. 2007;167:2066–72.

    Article  CAS  PubMed  Google Scholar 

  123. Valles J, Fernandez I, Alcaraz D, Chacon E, Cazorla A, Canals M, Mariscal D, Fontanals D, Moron A. Prospective randomized trial of 3 antiseptic solutions for prevention for catheter colonization in an intensive care unit for adult patients. Infect Control Hosp Epidemiol. 2008;29:847–53.

    Article  CAS  PubMed  Google Scholar 

  124. Darouiche RO, Wall MJ Jr, Itani KMF, Otterson MF, Webb AL, Carrick MM, Miller HJ, Awad SS, Crosby CT, Mosier MC, Alsharif A, Berger DH. Chlorhexidine- alcohol versus povidone- iodine for surgical-site antisepsis. N Engl J Med. 2010;362:18–26.

    Article  CAS  PubMed  Google Scholar 

  125. Onder AM, Chandar J, Coakley S, Francoeur D, Abitbol CL, Zilleruelo G. Controlling the exit site infections: does it decrease the incidence of catheter-related bacteremia in children on chronic hemodialysis? Hemodial Int. 2009;13:11–8.

    Article  PubMed  Google Scholar 

  126. Safdar N, O’Horo JC, Ghufran A, Bearden A, Didier ME, Chateau D, Maki DG. Chlorhexidine –impregnated dressing for prevention of catheter-related blood stream infection: a meta-analysis. Crit Care Med. 2014;42:1703–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Brncard R, Troche G, Gauzit R, Antona M. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012;186:1272–8.

    Article  CAS  PubMed  Google Scholar 

  128. Apata IW, Hanfelt J, Bailey JL, Niyyar VD. Chlorhexidine-impregnated transparent dressings decrease catheter-related infections in hemodialysis patients: a quality improvement project. J Vasc Access. 2017;18:103–8.

    Article  PubMed  Google Scholar 

  129. Centers for Disease Control and Prevention. Updated recommendations on the use of chlorhexidine-impregnated dressings for prevention of intravascular catheter-related infections. Available at: https://www.cdc.gov/infectioncontrol/guidelines/bsi/c-i-dressings/appendix/index.html. Accessed on 03/07/2019.

  130. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol. 2003;14:169–79.

    Article  CAS  PubMed  Google Scholar 

  131. Battistella M, Bhola C, Lok CE. Long-term follow-up of the hemodialysis infection prevention with Polysporin ointment (HIPPO) study: a quality improvement report. Am J Kidney Dis. 2011;57:432–41.

    Article  CAS  PubMed  Google Scholar 

  132. Mandal MD, Mandal S. Honey: its medicinal property and antibacterial activity. Asian Pac J Trop Biomed. 2017;7:901–8.

    Google Scholar 

  133. Kwakman PHS, Van den Akker JP, Guclu A, Aslami H, Binnekade JM, de Boer L, Boszhard L, Paulus F, Middelhoek P, te Velde AA, Vandenbroucke-Grauls CMJE, Schultz MJ, Zaat SAJ. Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization. Clin Infect Dis. 2008;46:1677–82.

    Article  CAS  PubMed  Google Scholar 

  134. Kwakman PHS, de Boer L, Ruyter-Spira CP, Creemers-Molenaar T, Helsper JPFG, Vandenbroucke-Grauls CMJE, Zaat SAJ, te Velde AA. Medical-grade honey enriched with antimicrobial peptides has enhanced activity against antibiotic-resistant pathogens. Eur J Clin Microbiol Infect Dis. 2011;30:251–7.

    Article  CAS  PubMed  Google Scholar 

  135. Johnson DW, van Eps C, Mudge DW, Wiggins KJ, Armstrong K, Hawley CM, Campbell SB, Isbel NM, Nimmo GR, Gibbs H. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections I hemodialysis patients. J Am Soc Nephrol. 2005;16:1456–62.

    Article  CAS  PubMed  Google Scholar 

  136. Hymes JL, Mooney A, Zandt CV, Lynch L, Ziebol R, Killion D. Dialysis catheter-related blood stream infections: a cluster-randomized trial of the ClearGuard HD antimicrobial barrier cap. Am J Kidney Dis. 2017;69:220–7.

    Article  PubMed  Google Scholar 

  137. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med. 1997;127:257–66.

    Article  CAS  PubMed  Google Scholar 

  138. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281:261–7.

    Article  CAS  PubMed  Google Scholar 

  139. Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ, Metzler MH, Shah S, Mansouri MD, Cerra-Stewart C, Versalovic J, Reardon MJ, Raad II. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters. Ann Surg. 2005;242:193–200.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Trerotola SO, Johnson MS, Shah H, Kraus MA, McKusky MA, Ambrosius WT, Harris VJ, Snidow JJ. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection – a randomized study. Radiology. 1998;207:491–6.

    Google Scholar 

  141. Chatzinikolaou I, Finkel K, Hanna H, Boktour M, Foringer J, Ho T, Raad II. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med. 2003;115:352–7.

    Article  CAS  PubMed  Google Scholar 

  142. Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keatimg K, Civetta JM, Mermel LA, Lee D, Dellinger EP, Donahoe M, Giles D, Pfaller MA, Maki DG, Sherertz R. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med. 2005;143:570–80.

    Article  CAS  PubMed  Google Scholar 

  143. Schindler R, Heemann U, Haug U, Stoelck B, Karatas A, Pohle C, Deppisch R, Beck W, Hollenbeck M. Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization: a randomized controlled trial. Nephrol Dial Transplant. 2010;25:2651–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Jain G, Allon M, Saddekni S, Barker JF, Maya ID. Does heparin coating improve patency or reduce infection of tunneled dialysis catheters? Clin J Am Soc Nephrol. 2009;4:1787–90.

    Article  PubMed  PubMed Central  Google Scholar 

  145. Mojibian H, Spector M, Ni N, Eliseo D, Pollak J, Tal M. Initial clinical experience with a new heparin-coated chronic hemodialysis catheter. Hemodial Int. 2009;13:329–34.

    Article  PubMed  Google Scholar 

  146. Bleyer AJ. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin J Am Soc Nephrol. 2007;2:1073–8.

    Article  CAS  PubMed  Google Scholar 

  147. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int. 2004;66:801–5.

    Article  PubMed  Google Scholar 

  148. Betjes MGH, Agteren MV. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant. 2004;19:1546–51.

    Article  CAS  PubMed  Google Scholar 

  149. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol. 2002;13:2133–9.

    Article  CAS  PubMed  Google Scholar 

  150. Vanholder R, Canaud B, Fluck R, Jadoul M, Labriola L, Marti-Monros A, Tordoir J, Van Biesen W. Diagnosis, prevention and treatment of haemodialysis catheter-related blood stream infections (CRBSI): a position statement of European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2010;3:234–46.

    Google Scholar 

  151. Moore CL, Besarab A, Ajluni M, Soi V, Peterson EL, Johnson LE, Zervos MJ, Adams E, Yee J. Comparative effectiveness of two catheter locking solutions to reduce catheter related bloodstream infection in hemodialysis patients. Clin J Am Soc Nephrol. 2014;9:1232–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  152. Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis. 2012;59:102–7.

    Article  CAS  PubMed  Google Scholar 

  153. Abbas SA, Haloob IA, Taylor SL, Curry EM, King BB, Van der Merwe WM, Marshall MR. Effect of antimicrobial locks for tunneled hemodialysis catheters on blood stream infection and bacterial resistance: a quality improvement report. Am J Kidney Dis. 2009;53:492–502.

    Article  PubMed  Google Scholar 

  154. Venditto M, du Montcel ST, Robert J, Trystam D, Dighiero J, Hue D, Bessette C, Deray G, Mercadal L. Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin. Blood Purif. 2010;29:268–73.

    Article  CAS  PubMed  Google Scholar 

  155. Fernandez-Gallego J, Martin M, Gitierrez E, Cobelo C, Frias P, Jironda C, Hidalgo P, Jimenez T. Prophylaxis with gentamicin locking of chronic tunneled central venous catheters does not cause bacterial resistance. Nefrologia. 2011;31:308–12.

    CAS  PubMed  Google Scholar 

  156. Onder AM, Chandar J, Simon N, Diaz R, Nwobi O, Abitbol CL, Zilleruelo G. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteremia. Nephrol Dial Transplant. 2008;23:2604–10.

    Article  CAS  PubMed  Google Scholar 

  157. Nori US, Manoharan A, Yee J, Besarab A. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis. 2006;48:596–605.

    Article  CAS  PubMed  Google Scholar 

  158. Wong B, Muneer M, Wiebe N, Storie D, Shurraw S, Pannu N, et al. Buttonhole versus rope-ladder cannulation of arteriovenous fistulas for hemodialysis: a systemic review. Am J Kidney Dis. 2014;64:918–36.

    Article  PubMed  Google Scholar 

  159. Ayus JC, Sheikh-Hamad D. Silent infection in clotted hemodialysis access grafts. J Am Soc Nephrol. 1998;9:1314–9.

    Article  CAS  PubMed  Google Scholar 

  160. Nassar GM, Ayus JC. Infectious complications of old nonfunctioning arteriovenous grafts in renal transplant recipients: a case series. Am J Kidney Dis. 2002;40:832–5.

    Article  PubMed  Google Scholar 

  161. Snydman DR, Bregman D, Bryan J. Hemodialysis-associated hepatitis in the United States, 1974. J Infect Dis. 1977;135:687–91.

    Article  Google Scholar 

  162. Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 1997. Semin Dial. 2000;13:75–85.

    Article  CAS  PubMed  Google Scholar 

  163. Sheth R, Peskin MF, Du XI. The duration of hepatitis B vaccine immunity in pediatric dialysis patients. Pediatr Nephrol. 2014;29:2029–37.

    Article  PubMed  Google Scholar 

  164. Yi SH, Kallen AJ, Hess S, Bren VR, Lincoln ME, Downham G, Kelley K, Booth SL, Weirich H, Shugart A, Lines C, Melville A, Jernigan JA, Kleinbaum DG, Patel PR. Sustained infection reduction in outpatient hemodialysis centers participating in a collaborative bloodstream infection prevention effort. Infect Control Hosp Epidemiol. 2016;37:863–6.

    Article  PubMed  Google Scholar 

  165. Neu AM, Miller MR, Stuart J, Lawlor J, Richardson T, Martz K, Rosenberg C, Newland J, McAfee N, Begin B, Warady BA, Collaborative Participants SCOPE. Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative. Pediatr Nephrol. 2014;29:1477–84.

    Article  PubMed  Google Scholar 

  166. Marsenic O, Rodean J, Richardson T, Swartz S, Claes D, Day JC, Warady BA, Neu AM, on behalf of the SCOPE Investigators. Tunneled hemodialysis catheter care practices and blood stream infection rate in children: results from the SCOPE collaborative. Pediatr Nephrol. 2020;35:135–43.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Batson Children’s Hospital of Mississippi, Jackson, MS, USA

    Ali Mirza Onder

  2. Division of Nephrology, Boston Children’s Hospital, Boston, MA, USA

    Michael J. G. Somers

Authors
  1. Ali Mirza Onder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. G. Somers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. G. Somers .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University of Missouri-Kansas City, School of Medicine, Division of Pediatric Nephrology, Children’s Mercy Kansas City, Kansas City, MO, USA

    Bradley A. Warady

  2. Stanford University School of Medicine, Division of Pediatric Nephrology, Department of Pediatrics, Palo Alto, CA, USA

    Steven R. Alexander

  3. Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany

    Franz Schaefer

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Onder, A.M., Somers, M.J.G. (2021). Infectious Complications of Hemodialysis in Children. In: Warady, B.A., Alexander, S.R., Schaefer, F. (eds) Pediatric Dialysis. Springer, Cham. https://doi.org/10.1007/978-3-030-66861-7_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-66861-7_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-66860-0

  • Online ISBN: 978-3-030-66861-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation